You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Measurable Residual Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Digital Droplet PCR in Early Period After Allo-HSCT to Predict

Completed
  • Measurable Residual Disease
  • Digital Droplet PCR
  • Hangzhou, Zhejiang, China
    The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 17, 2023

Measurable Residual Disease in Acute Myeloid Leukemia as

Terminated
  • Leukemia, Myeloid, Acute
  • Measurable residual disease measured by flow cytometry
  • Heidelberg, BW, Germany
    University Hospital Heidelberg
Sep 12, 2022

MDS Trial in Saint Louis (DEC-C, MyeloSeq-HD)

Recruiting
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 18, 2023

AML, Adult, Minimal Residual Disease Trial (MRD assessment)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • MRD assessment
  • (no location specified)
Oct 13, 2023

Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Cytokine Induced Memory-like Natural Killer Cells
  • Interleukin-2
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Acute Myeloid Leukemia Trial in Los Angeles, San Francisco (Azacitidine, Tagraxofusp-erzs)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +1 more
Jan 31, 2023

Mixed Phenotype Acute Leukemia (MPAL), Measurable Residual Disease (MRD) Trial in Baltimore (BLINCYTO (Blinatumomab))

Recruiting
  • Mixed Phenotype Acute Leukemia (MPAL)
  • Measurable Residual Disease (MRD)
  • BLINCYTO (Blinatumomab)
  • Baltimore, Maryland
    Greenebaum Cancer Center at University of Maryland Medical Cente
Apr 18, 2022

Clinical Pathways for Newly Diagnosed Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Multiple Myeloma Without Mention of Remission
  • Multiple Myeloma Pathway
  • +2 more
  • (no location specified)
Nov 27, 2023

AML Patients After Stem Cell Transplant to Understand Relapse

Recruiting
  • Acute Myeloid Leukemia in Remission
  • Prospective determination of the clinical utility of measurable residual disease (MRD) testing
  • Duarte, California
  • +3 more
Dec 7, 2022

Acute Myeloid Leukemia Trial in Worldwide (Sabatolimab, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • Marseille, France
  • +11 more
Mar 29, 2022

Acute Lymphoblastic Leukemia Trial in Bergamo, Monza (PTG-CARCIK-CD19)

Recruiting
  • Acute Lymphoblastic Leukemia
  • PTG-CARCIK-CD19
  • Bergamo, Italy
  • +1 more
Feb 12, 2022

Leukemia, Myeloid, Acute Trial (Cytarabine, Venetoclax, CPX-351)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • (no location specified)
Nov 25, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Birmingham, Alabama
  • +8 more
Jan 24, 2023

Acute Myeloid Leukemia Trial in Worldwide (Cyclophosphamide-Fludarabine (Cy/Flu), oNKord®)

Recruiting
  • Acute Myeloid Leukemia
  • Cyclophosphamide-Fludarabine (Cy/Flu)
  • oNKord®
  • Ghent, Belgium
  • +9 more
Jun 15, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Greenwich, Connecticut
  • +27 more
Dec 30, 2022

Multiple Myeloma Trial in Chicago (Screening Phase, Discontinuation Phase)

Recruiting
  • Multiple Myeloma
  • Screening Phase
  • Discontinuation Phase
  • Chicago, Illinois
    University Of Chicago Medicine Comprehensive Cancer Center
Jan 8, 2021

Acute Myeloid Leukemia Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Nov 4, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Arising

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • (no location specified)
Nov 8, 2022

NPMc+ AML Trial in Hong Kong (Oral Arsenic Trioxide Formulation)

Recruiting
  • NPMc+ AML
  • Oral Arsenic Trioxide Formulation
  • Hong Kong, Hong Kong
    The University of Hong Kong
Dec 29, 2020

Leukemia, Myeloid, Acute Trial in Spain (Idarubicin, Ara-C, G-CSF)

Recruiting
  • Leukemia, Myeloid, Acute
  • Badalona, Barcelona, Spain
  • +14 more
Jul 30, 2021

Minimal Residual Disease Using Multi-omics Approach

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
  • Shanghai, China
    Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Nov 29, 2023

Minimally Residual of Esophageal Cancer 001

Recruiting
  • Esophageal Carcinoma
  • Minimal Residual Disease
    • Shijiazhuang, Hebei, China
      Fourth Hospital of Hebei Medical University
    Jul 17, 2023

    Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Pembrolizumab injection
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 20, 2023

    HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy Trial (SHR-A1811,

    Not yet recruiting
    • HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
    • (no location specified)
    Nov 7, 2023

    B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

    Recruiting
    • B-Cell Lymphoblastic Leukemia
    • Acute Lymphoblastic Leukemia
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 28, 2023